Index Terms Starting With 'L' (Long-term)

  • Long-term (current) (prophylactic) drug therapy (use of)

    • 5-fluorouracil Z79.631
      ICD-10-CM Diagnosis Code Z79.631

      Long term (current) use of antimetabolite agent

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of 5-fluorouracil
      • Long term (current) use of 6-mercaptopurine
      • Long term (current) use of cytarabine
      • Long term (current) use of methotrexate
    • 6-mercaptopurine Z79.631
      ICD-10-CM Diagnosis Code Z79.631

      Long term (current) use of antimetabolite agent

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of 5-fluorouracil
      • Long term (current) use of 6-mercaptopurine
      • Long term (current) use of cytarabine
      • Long term (current) use of methotrexate
    • adalimumab Z79.620
      ICD-10-CM Diagnosis Code Z79.620

      Long term (current) use of immunosuppressive biologic

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of adalimumab
      • Long term (current) use of etanercept
      • Long term (current) use of infliximab
      • Long term (current) use of monoclonal antibodies
    • agents affecting estrogen receptors and estrogen levels NEC Z79.818
      ICD-10-CM Diagnosis Code Z79.818

      Long term (current) use of other agents affecting estrogen receptors and estrogen levels

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of estrogen receptor downregulators
      • Long term (current) use of fulvestrant (Faslodex)
      • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
      • Long term (current) use of goserelin acetate (Zoladex)
      • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
      • Long term (current) use of megestrol acetate (Megace)
    • alkylating agent Z79.630
      ICD-10-CM Diagnosis Code Z79.630

      Long term (current) use of alkylating agent

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of chlorambucil
      • Long term (current) use of cisplatin
      • Long term (current) use of cyclophosphamide
    • anastrozole Z79.811
      (Arimidex)
      ICD-10-CM Diagnosis Code Z79.811

      Long term (current) use of aromatase inhibitors

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of anastrozole (Arimidex)
      • Long term (current) use of exemestane (Aromasin)
      • Long term (current) use of letrozole (Femara)
    • anti-inflammatory, non-steroidal Z79.1
      (NSAID)
      ICD-10-CM Diagnosis Code Z79.1

      Long term (current) use of non-steroidal anti-inflammatories (NSAID)

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Type 2 Excludes
      • long term (current) use of aspirin (Z79.82)
    • antibiotics Z79.2
      ICD-10-CM Diagnosis Code Z79.2

      Long term (current) use of antibiotics

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      • short-term use - omit code
    • anticoagulants Z79.01
      ICD-10-CM Diagnosis Code Z79.01

      Long term (current) use of anticoagulants

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    • antidiabetic drugs, injectable, non-insulin Z79.85
      ICD-10-CM Diagnosis Code Z79.85

      Long-term (current) use of injectable non-insulin antidiabetic drugs

        2023 - New Code Billable/Specific Code POA Exempt
      Type 2 Excludes
      • long term (current) use of insulin (Z79.4)
      • long term (current) use of oral hypoglycemic drugs (Z79.84)
    • antimetabolite agent Z79.631
      ICD-10-CM Diagnosis Code Z79.631

      Long term (current) use of antimetabolite agent

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of 5-fluorouracil
      • Long term (current) use of 6-mercaptopurine
      • Long term (current) use of cytarabine
      • Long term (current) use of methotrexate
    • antiplatelet Z79.02
      ICD-10-CM Diagnosis Code Z79.02

      Long term (current) use of antithrombotics/antiplatelets

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    • antithrombotics Z79.02
      ICD-10-CM Diagnosis Code Z79.02

      Long term (current) use of antithrombotics/antiplatelets

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    • antitumor antibiotic Z79.632
      ICD-10-CM Diagnosis Code Z79.632

      Long term (current) use of antitumor antibiotic

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of bleomycin
      • Long term (current) use of doxorubicin
      • Long term (current) use of mitomycin C
    • apremilast Z79.61
      ICD-10-CM Diagnosis Code Z79.61

      Long term (current) use of immunomodulator

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of apremilast
      • Long term (current) use of immunomodulatory imide drug
      • Long term (current) use of lenalidomide
      • Long term (current) use of pomalidomide
    • aromatase inhibitors Z79.811
      ICD-10-CM Diagnosis Code Z79.811

      Long term (current) use of aromatase inhibitors

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of anastrozole (Arimidex)
      • Long term (current) use of exemestane (Aromasin)
      • Long term (current) use of letrozole (Femara)
    • aspirin Z79.82
      ICD-10-CM Diagnosis Code Z79.82

      Long term (current) use of aspirin

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    • azathioprine Z79.624
      ICD-10-CM Diagnosis Code Z79.624

      Long term (current) use of inhibitors of nucleotide synthesis

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of azathioprine
      • Long term (current) use omycophenolate
      • Long term (current) use of purine synthesis (IMDH) inhibitors
    • birth control pill or patch Z79.3
      ICD-10-CM Diagnosis Code Z79.3

      Long term (current) use of hormonal contraceptives

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of birth control pill or patch
    • bisphosphonates Z79.83
      ICD-10-CM Diagnosis Code Z79.83

      Long term (current) use of bisphosphonates

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    • bleomycin Z79.632
      ICD-10-CM Diagnosis Code Z79.632

      Long term (current) use of antitumor antibiotic

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of bleomycin
      • Long term (current) use of doxorubicin
      • Long term (current) use of mitomycin C
    • calcineurin inhibitor Z79.621
      ICD-10-CM Diagnosis Code Z79.621

      Long term (current) use of calcineurin inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of cyclosporine
      • Long term (current) use of tacrolimus
    • chlorambucil Z79.630
      ICD-10-CM Diagnosis Code Z79.630

      Long term (current) use of alkylating agent

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of chlorambucil
      • Long term (current) use of cisplatin
      • Long term (current) use of cyclophosphamide
    • cisplatin Z79.630
      ICD-10-CM Diagnosis Code Z79.630

      Long term (current) use of alkylating agent

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of chlorambucil
      • Long term (current) use of cisplatin
      • Long term (current) use of cyclophosphamide
    • contraceptive, oral Z79.3
      ICD-10-CM Diagnosis Code Z79.3

      Long term (current) use of hormonal contraceptives

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of birth control pill or patch
    • cyclophosphamide Z79.630
      ICD-10-CM Diagnosis Code Z79.630

      Long term (current) use of alkylating agent

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of chlorambucil
      • Long term (current) use of cisplatin
      • Long term (current) use of cyclophosphamide
    • cyclosporine Z79.621
      ICD-10-CM Diagnosis Code Z79.621

      Long term (current) use of calcineurin inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of cyclosporine
      • Long term (current) use of tacrolimus
    • cytarabine Z79.631
      ICD-10-CM Diagnosis Code Z79.631

      Long term (current) use of antimetabolite agent

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of 5-fluorouracil
      • Long term (current) use of 6-mercaptopurine
      • Long term (current) use of cytarabine
      • Long term (current) use of methotrexate
    • doxorubicin Z79.632
      ICD-10-CM Diagnosis Code Z79.632

      Long term (current) use of antitumor antibiotic

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of bleomycin
      • Long term (current) use of doxorubicin
      • Long term (current) use of mitomycin C
    • drug, specified NEC Z79.899
      ICD-10-CM Diagnosis Code Z79.899

      Other long term (current) drug therapy

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    • estrogen receptor downregulators Z79.818
      ICD-10-CM Diagnosis Code Z79.818

      Long term (current) use of other agents affecting estrogen receptors and estrogen levels

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of estrogen receptor downregulators
      • Long term (current) use of fulvestrant (Faslodex)
      • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
      • Long term (current) use of goserelin acetate (Zoladex)
      • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
      • Long term (current) use of megestrol acetate (Megace)
    • etanercept Z79.620
      ICD-10-CM Diagnosis Code Z79.620

      Long term (current) use of immunosuppressive biologic

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of adalimumab
      • Long term (current) use of etanercept
      • Long term (current) use of infliximab
      • Long term (current) use of monoclonal antibodies
    • etoposide Z79.634
      ICD-10-CM Diagnosis Code Z79.634

      Long term (current) use of topoisomerase inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of etoposide
      • Long term (current) use of irinotecan
      • Long term (current) use of topotecan
    • Evista Z79.810
      ICD-10-CM Diagnosis Code Z79.810

      Long term (current) use of selective estrogen receptor modulators (SERMs)

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of raloxifene (Evista)
      • Long term (current) use of tamoxifen (Nolvadex)
      • Long term (current) use of toremifene (Fareston)
    • exemestane Z79.811
      (Aromasin)
      ICD-10-CM Diagnosis Code Z79.811

      Long term (current) use of aromatase inhibitors

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of anastrozole (Arimidex)
      • Long term (current) use of exemestane (Aromasin)
      • Long term (current) use of letrozole (Femara)
    • Fareston Z79.810
      ICD-10-CM Diagnosis Code Z79.810

      Long term (current) use of selective estrogen receptor modulators (SERMs)

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of raloxifene (Evista)
      • Long term (current) use of tamoxifen (Nolvadex)
      • Long term (current) use of toremifene (Fareston)
    • fulvestrant Z79.818
      (Faslodex)
      ICD-10-CM Diagnosis Code Z79.818

      Long term (current) use of other agents affecting estrogen receptors and estrogen levels

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of estrogen receptor downregulators
      • Long term (current) use of fulvestrant (Faslodex)
      • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
      • Long term (current) use of goserelin acetate (Zoladex)
      • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
      • Long term (current) use of megestrol acetate (Megace)
    • gonadotropin-releasing hormone Z79.818
      (GnRH)
      ICD-10-CM Diagnosis Code Z79.818

      Long term (current) use of other agents affecting estrogen receptors and estrogen levels

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of estrogen receptor downregulators
      • Long term (current) use of fulvestrant (Faslodex)
      • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
      • Long term (current) use of goserelin acetate (Zoladex)
      • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
      • Long term (current) use of megestrol acetate (Megace)
    • goserelin acetate Z79.818
      (Zoladex)
      ICD-10-CM Diagnosis Code Z79.818

      Long term (current) use of other agents affecting estrogen receptors and estrogen levels

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of estrogen receptor downregulators
      • Long term (current) use of fulvestrant (Faslodex)
      • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
      • Long term (current) use of goserelin acetate (Zoladex)
      • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
      • Long term (current) use of megestrol acetate (Megace)
    • hormone replacement Z79.890
      ICD-10-CM Diagnosis Code Z79.890

      Hormone replacement therapy

        2016 2017 2018 - Revised Code 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    • hydroxyurea Z79.64
      ICD-10-CM Diagnosis Code Z79.64

      Long term (current) use of myelosuppressive agent

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of hydroxyurea
    • immunomodulators, unspecified Z79.60
      ICD-10-CM Diagnosis Code Z79.60

      Long term (current) use of unspecified immunomodulators and immunosuppressants

        2023 - New Code Billable/Specific Code POA Exempt
      • specified NEC Z79.69
        ICD-10-CM Diagnosis Code Z79.69

        Long term (current) use of other immunomodulators and immunosuppressants

          2023 - New Code Billable/Specific Code POA Exempt
    • immunomodulatory imide drug Z79.61
      ICD-10-CM Diagnosis Code Z79.61

      Long term (current) use of immunomodulator

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of apremilast
      • Long term (current) use of immunomodulatory imide drug
      • Long term (current) use of lenalidomide
      • Long term (current) use of pomalidomide
    • immunosuppressants, unspecified Z79.60
      ICD-10-CM Diagnosis Code Z79.60

      Long term (current) use of unspecified immunomodulators and immunosuppressants

        2023 - New Code Billable/Specific Code POA Exempt
      • specified NEC Z79.69
        ICD-10-CM Diagnosis Code Z79.69

        Long term (current) use of other immunomodulators and immunosuppressants

          2023 - New Code Billable/Specific Code POA Exempt
    • immunosuppressive biologic Z79.620
      ICD-10-CM Diagnosis Code Z79.620

      Long term (current) use of immunosuppressive biologic

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of adalimumab
      • Long term (current) use of etanercept
      • Long term (current) use of infliximab
      • Long term (current) use of monoclonal antibodies
    • infliximab Z79.620
      ICD-10-CM Diagnosis Code Z79.620

      Long term (current) use of immunosuppressive biologic

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of adalimumab
      • Long term (current) use of etanercept
      • Long term (current) use of infliximab
      • Long term (current) use of monoclonal antibodies
    • inhibitors of nucleotide synthesis Z79.624
      ICD-10-CM Diagnosis Code Z79.624

      Long term (current) use of inhibitors of nucleotide synthesis

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of azathioprine
      • Long term (current) use omycophenolate
      • Long term (current) use of purine synthesis (IMDH) inhibitors
    • insulin Z79.4
      ICD-10-CM Diagnosis Code Z79.4

      Long term (current) use of insulin

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Type 2 Excludes
      • long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
      • long term (current) use of oral antidiabetic drugs (Z79.84)
      • long term (current) use of oral hypoglycemic drugs (Z79.84)
    • irinotecan Z79.634
      ICD-10-CM Diagnosis Code Z79.634

      Long term (current) use of topoisomerase inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of etoposide
      • Long term (current) use of irinotecan
      • Long term (current) use of topotecan
    • Janus kinase inhibitor Z79.622
      ICD-10-CM Diagnosis Code Z79.622

      Long term (current) use of Janus kinase inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of tofacitinib
    • lenalidomide Z79.61
      ICD-10-CM Diagnosis Code Z79.61

      Long term (current) use of immunomodulator

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of apremilast
      • Long term (current) use of immunomodulatory imide drug
      • Long term (current) use of lenalidomide
      • Long term (current) use of pomalidomide
    • letrozole Z79.811
      (Femara)
      ICD-10-CM Diagnosis Code Z79.811

      Long term (current) use of aromatase inhibitors

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of anastrozole (Arimidex)
      • Long term (current) use of exemestane (Aromasin)
      • Long term (current) use of letrozole (Femara)
    • leuprolide acetate Z79.818
      (leuprorelin) (Lupron)
      ICD-10-CM Diagnosis Code Z79.818

      Long term (current) use of other agents affecting estrogen receptors and estrogen levels

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of estrogen receptor downregulators
      • Long term (current) use of fulvestrant (Faslodex)
      • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
      • Long term (current) use of goserelin acetate (Zoladex)
      • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
      • Long term (current) use of megestrol acetate (Megace)
    • mammalian target of rapamycin Z79.623
      (mTOR)
      ICD-10-CM Diagnosis Code Z79.623

      Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of sirolimus
    • megestrol acetate Z79.818
      (Megace)
      ICD-10-CM Diagnosis Code Z79.818

      Long term (current) use of other agents affecting estrogen receptors and estrogen levels

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of estrogen receptor downregulators
      • Long term (current) use of fulvestrant (Faslodex)
      • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
      • Long term (current) use of goserelin acetate (Zoladex)
      • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
      • Long term (current) use of megestrol acetate (Megace)
    • methadone for pain management Z79.891
      ICD-10-CM Diagnosis Code Z79.891

      Long term (current) use of opiate analgesic

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of methadone for pain management
      Type 1 Excludes
      • methodone use NOS (F11.9-)
      • use of methodone for treatment of heroin addiction (F11.2-)
    • mitomycin C Z79.632
      ICD-10-CM Diagnosis Code Z79.632

      Long term (current) use of antitumor antibiotic

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of bleomycin
      • Long term (current) use of doxorubicin
      • Long term (current) use of mitomycin C
    • mitotic inhibitor Z79.633
      ICD-10-CM Diagnosis Code Z79.633

      Long term (current) use of mitotic inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of paclitaxel
      • Long term (current) use of plant alkaloids
      • Long term (current) use of vinblastine
      • Long term (current) use of vincristine
    • monoclonal antibodies Z79.620
      ICD-10-CM Diagnosis Code Z79.620

      Long term (current) use of immunosuppressive biologic

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of adalimumab
      • Long term (current) use of etanercept
      • Long term (current) use of infliximab
      • Long term (current) use of monoclonal antibodies
    • myelosuppressive agent Z79.64
      ICD-10-CM Diagnosis Code Z79.64

      Long term (current) use of myelosuppressive agent

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of hydroxyurea
    • Nolvadex Z79.810
      ICD-10-CM Diagnosis Code Z79.810

      Long term (current) use of selective estrogen receptor modulators (SERMs)

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of raloxifene (Evista)
      • Long term (current) use of tamoxifen (Nolvadex)
      • Long term (current) use of toremifene (Fareston)
    • non-insulin antidiabetic drug, injectable Z79.899
      ICD-10-CM Diagnosis Code Z79.899

      Other long term (current) drug therapy

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    • non-steroidal anti-inflammatories Z79.1
      (NSAID)
      ICD-10-CM Diagnosis Code Z79.1

      Long term (current) use of non-steroidal anti-inflammatories (NSAID)

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Type 2 Excludes
      • long term (current) use of aspirin (Z79.82)
    • omycophenolate Z79.624
      ICD-10-CM Diagnosis Code Z79.624

      Long term (current) use of inhibitors of nucleotide synthesis

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of azathioprine
      • Long term (current) use omycophenolate
      • Long term (current) use of purine synthesis (IMDH) inhibitors
    • opiate analgesic Z79.891
      ICD-10-CM Diagnosis Code Z79.891

      Long term (current) use of opiate analgesic

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of methadone for pain management
      Type 1 Excludes
      • methodone use NOS (F11.9-)
      • use of methodone for treatment of heroin addiction (F11.2-)
    • oral
      • antidiabetic Z79.84
        ICD-10-CM Diagnosis Code Z79.84

        Long term (current) use of oral hypoglycemic drugs

          2017 - New Code 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
        Applicable To
        • Long term (current) use of oral antidiabetic drugs
        Type 2 Excludes
        • long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
        • long term (current) use of insulin (Z79.4)
      • contraceptive Z79.3
        ICD-10-CM Diagnosis Code Z79.3

        Long term (current) use of hormonal contraceptives

          2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
        Applicable To
        • Long term (current) use of birth control pill or patch
      • hypoglycemic Z79.84
        ICD-10-CM Diagnosis Code Z79.84

        Long term (current) use of oral hypoglycemic drugs

          2017 - New Code 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
        Applicable To
        • Long term (current) use of oral antidiabetic drugs
        Type 2 Excludes
        • long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
        • long term (current) use of insulin (Z79.4)
    • paclitaxel Z79.633
      ICD-10-CM Diagnosis Code Z79.633

      Long term (current) use of mitotic inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of paclitaxel
      • Long term (current) use of plant alkaloids
      • Long term (current) use of vinblastine
      • Long term (current) use of vincristine
    • plant alkaloids Z79.633
      ICD-10-CM Diagnosis Code Z79.633

      Long term (current) use of mitotic inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of paclitaxel
      • Long term (current) use of plant alkaloids
      • Long term (current) use of vinblastine
      • Long term (current) use of vincristine
    • pomalidomide Z79.61
      ICD-10-CM Diagnosis Code Z79.61

      Long term (current) use of immunomodulator

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of apremilast
      • Long term (current) use of immunomodulatory imide drug
      • Long term (current) use of lenalidomide
      • Long term (current) use of pomalidomide
    • purine synthesis Z79.624
      (IMDH)
      ICD-10-CM Diagnosis Code Z79.624

      Long term (current) use of inhibitors of nucleotide synthesis

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of azathioprine
      • Long term (current) use omycophenolate
      • Long term (current) use of purine synthesis (IMDH) inhibitors
    • raloxifene Z79.810
      (Evista)
      ICD-10-CM Diagnosis Code Z79.810

      Long term (current) use of selective estrogen receptor modulators (SERMs)

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of raloxifene (Evista)
      • Long term (current) use of tamoxifen (Nolvadex)
      • Long term (current) use of toremifene (Fareston)
    • selective estrogen receptor modulators Z79.810
      (SERMs)
      ICD-10-CM Diagnosis Code Z79.810

      Long term (current) use of selective estrogen receptor modulators (SERMs)

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of raloxifene (Evista)
      • Long term (current) use of tamoxifen (Nolvadex)
      • Long term (current) use of toremifene (Fareston)
    • sirolimus Z79.623
      ICD-10-CM Diagnosis Code Z79.623

      Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of sirolimus
    • steroids
      • inhaled Z79.51
        ICD-10-CM Diagnosis Code Z79.51

        Long term (current) use of inhaled steroids

          2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      • systemic Z79.52
        ICD-10-CM Diagnosis Code Z79.52

        Long term (current) use of systemic steroids

          2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    • tacrolimus Z79.621
      ICD-10-CM Diagnosis Code Z79.621

      Long term (current) use of calcineurin inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of cyclosporine
      • Long term (current) use of tacrolimus
    • tamoxifen Z79.810
      (Nolvadex)
      ICD-10-CM Diagnosis Code Z79.810

      Long term (current) use of selective estrogen receptor modulators (SERMs)

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of raloxifene (Evista)
      • Long term (current) use of tamoxifen (Nolvadex)
      • Long term (current) use of toremifene (Fareston)
    • tofacitinib Z79.622
      ICD-10-CM Diagnosis Code Z79.622

      Long term (current) use of Janus kinase inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of tofacitinib
    • topoisomerase inhibitor Z79.634
      ICD-10-CM Diagnosis Code Z79.634

      Long term (current) use of topoisomerase inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of etoposide
      • Long term (current) use of irinotecan
      • Long term (current) use of topotecan
    • topotecan Z79.634
      ICD-10-CM Diagnosis Code Z79.634

      Long term (current) use of topoisomerase inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of etoposide
      • Long term (current) use of irinotecan
      • Long term (current) use of topotecan
    • toremifene Z79.810
      (Fareston)
      ICD-10-CM Diagnosis Code Z79.810

      Long term (current) use of selective estrogen receptor modulators (SERMs)

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of raloxifene (Evista)
      • Long term (current) use of tamoxifen (Nolvadex)
      • Long term (current) use of toremifene (Fareston)
    • vinblastine Z79.633
      ICD-10-CM Diagnosis Code Z79.633

      Long term (current) use of mitotic inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of paclitaxel
      • Long term (current) use of plant alkaloids
      • Long term (current) use of vinblastine
      • Long term (current) use of vincristine
    • vincristine Z79.633
      ICD-10-CM Diagnosis Code Z79.633

      Long term (current) use of mitotic inhibitor

        2023 - New Code Billable/Specific Code POA Exempt
      Applicable To
      • Long term (current) use of paclitaxel
      • Long term (current) use of plant alkaloids
      • Long term (current) use of vinblastine
      • Long term (current) use of vincristine